Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients

NCT05663983 | Unknown

• 1 other identifier: AYA
• Study Type: observational
• Target: 600
• Locations: 0 countries
• Sites: N/A

Brief Summary

The principal aim of this study is to collect retrospectively all Adolescent Young Adult patients affected by Hodgkin's Lymphoma and treated in pediatric or adult haemato-oncology Centers. The data set collection aims to define the therapy performed and the results obtained in terms of overall survival and acute or late complications.

Conditions

Hodgkin Lymphoma; Adolescent Behavior; Chemotherapy Effect

Outcome Measures

Primary Outcomes (1)

• Overall survival according to different treatment.

  To evaluate if there are differences in treatment of pediatric or adult subset of patients

  2004 to 2016

Secondary Outcomes (2)

• Acute or late complications

  2004 to 2016

• Progression free survival

  2004 to 2016

Study Arms (2)

AIEOP

This is a National Association for the treatment of pediatric patients with hematological or oncological disease

Behavioral: Description of therapeutical results

FIL

This is a National Association that brings together many centers with particular attention to the treatment of adult lymphomas

Behavioral: Description of therapeutical results

Interventions

Description of therapeutical results BEHAVIORAL

Comparison between two groups of patients treated in different realities (Pediatric Hospital or Adult General Hospital)

AIEOP; FIL

Eligibility Criteria

• Age: 15 Years - 24 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

This is a retrospective observational study involving Italian Centers that treat adolescents and young adults Hodgkin lymphoma patients. This type of patients can be treated either in a Pediatric Institution or in Adult Institution with different supportive and therapeutical approaches.

You may qualify if:

• All consecutive patients with diagnosis of Hodgkin Lymphoma with an age at diagnosis ranging between 15 and 24 years enrolled in prospective studies either in AIEOP group and in FIL group or patients treated consecutively in single centers affiliated to AIEOP or FIL and registered in single institutional data base.
• All Hodgkin subtype

You may not qualify if:

• None

Sponsors & Collaborators

• Campus Bio-Medico University: lead
• Associazione Italiana di Ematologia e Oncologia Pediatrica: collaborator
• Fondazione Italiana Linfomi: collaborator

MeSH Terms

Conditions

Hodgkin Disease; Adolescent Behavior

Condition Hierarchy (Ancestors)

Lymphoma; Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Behavior

Central Study Contacts

Rigacci

CONTACT

00393408142040; l.rigacci@policlinicocampus.it

Donnini

CONTACT

a.donnini@policlinicocampus.it

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 2 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Trial Office Campus Bio-Medico

Study Record Dates

• First Submitted: December 7, 2022
• First Posted: December 23, 2022
• Study Start: January 1, 2023
• Primary Completion: December 1, 2023
• Study Completion: December 1, 2024
• Last Updated: December 23, 2022

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, CSR